{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:52:35Z","timestamp":1790787155220,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T00:00:00Z","timestamp":1440201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25460335"],"award-info":[{"award-number":["25460335"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25870496"],"award-info":[{"award-number":["25870496"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25929029"],"award-info":[{"award-number":["25929029"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jphs.2015.08.006","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T13:27:13Z","timestamp":1440854833000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats"],"prefix":"10.1016","volume":"129","author":[{"given":"Shota","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kaname","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Shirahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2015.08.006_bib1","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jphs.2015.08.006_bib2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3109\/10428194.2010.483303","article-title":"Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies","volume":"51","author":"Cavaletti","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jphs.2015.08.006_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.leukres.2009.07.022","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients","volume":"34","author":"Corso","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.jphs.2015.08.006_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejca.2008.10.004","article-title":"Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy","volume":"45","author":"Kawashiri","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jphs.2015.08.006_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejpain.2010.08.006","article-title":"Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model","volume":"15","author":"Kawashiri","year":"2011","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2012.08.023","article-title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","volume":"238","author":"Zheng","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jphs.2015.08.006_bib8","doi-asserted-by":"crossref","first-page":"e72995","DOI":"10.1371\/journal.pone.0072995","article-title":"Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse","volume":"8","author":"Carozzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2015.08.006_bib9","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1158\/0008-5472.CAN-12-4370","article-title":"Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade","volume":"73","author":"Trevisan","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jphs.2015.08.006_bib10","first-page":"5453","article-title":"Antibody against tumor necrosis factor-\u03b1 reduces bortezomib-induced allodynia in a rat model","volume":"33","author":"Chiorazzi","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jphs.2015.08.006_bib11","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.pain.2013.07.032","article-title":"Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase","volume":"154","author":"Janes","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib12","first-page":"180428","article-title":"Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve","author":"Quartu","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jphs.2015.08.006_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brainres.2014.06.013","article-title":"Altered discharges of spinal neurons parallel the behavioral phenotype shown by rats with bortezomib related chemotherapy induced peripheral neuropathy","volume":"1574","author":"Robinson","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.jphs.2015.08.006_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbi.2014.01.020","article-title":"TNF-\u03b1-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy","volume":"38","author":"Zhang","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jphs.2015.08.006_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1254\/jphs.13274FP","article-title":"Gabapentin inhibits bortezomib-induced mechanical allodynia through supraspinal action in mice","volume":"124","author":"Kitamura","year":"2014","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2015.08.006_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2003.11.050","article-title":"V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze","volume":"356","author":"Egashira","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jphs.2015.08.006_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0304-3959(01)00481-X","article-title":"Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors","volume":"96","author":"Taiwo","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1254\/jphs.10012SC","article-title":"Mexiletine reverses oxaliplatin-induced neuropathic pain in rats","volume":"112","author":"Egashira","year":"2010","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2015.08.006_bib21","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/j.1532-2149.2012.00142.x","article-title":"Automated measurement of spontaneous pain-associated limb movement and drug efficacy evaluation in a rat model of neuropathic pain","volume":"16","author":"Kawasaki-Yatsugi","year":"2012","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.pain.2012.01.022","article-title":"Afferent drive elicits ongoing pain in a model of advanced osteoarthritis","volume":"153","author":"Okun","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2011.12.002","article-title":"Effect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis models","volume":"676","author":"Oyama","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2015.08.006_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lfs.2012.12.009","article-title":"Combined antiallodynic effect of Neurotropin\u00ae and pregabalin in rats with L5-spinal nerve ligation","volume":"92","author":"Okazaki","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2015.08.006_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/mcne.1999.0814","article-title":"Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury","volume":"15","author":"Tsujino","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jphs.2015.08.006_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jphs.2015.08.006_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.expneurol.2010.02.006","article-title":"Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice","volume":"223","author":"Bruna","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jphs.2015.08.006_bib28","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/glia.21065","article-title":"Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy","volume":"58","author":"Shin","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jphs.2015.08.006_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuro.2013.09.001","article-title":"Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons","volume":"39","author":"Staff","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jphs.2015.08.006_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3959(98)00091-8","article-title":"Wallerian degeneration and hyperalgesia after peripheral nerve injury are glutathione-dependent","volume":"77","author":"Wagner","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2015.08.006_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1526-4637.2007.00301.x","article-title":"Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies","volume":"9","author":"Xiao","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jphs.2015.08.006_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuroscience.2010.05.019","article-title":"Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in\u00a0vivo neuropathic pain models","volume":"169","author":"Ghelardini","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jphs.2015.08.006_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.111.187401","article-title":"Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia","volume":"342","author":"Ito","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2015.08.006_bib34","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1002\/jnr.21786","article-title":"Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury","volume":"86","author":"Tanabe","year":"2008","journal-title":"J\u00a0Neurosci Res"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T22:27:16Z","timestamp":1537396036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861315001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1347861315001814"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2015.08.006","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2015.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}